{"disease":{"id":"sedation-as-adjunct-to-anesthesia","name":"Sedation as Adjunct to Anesthesia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":11,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"midazolam-hydrochloride","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"Midazolam Hydrochloride","company_name":"Takeda Pharmaceutical Company Limited","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-5/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":58,"revenue":null,"mechanism":""},{"drug_id":"midazolam","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"midazolam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Cytochrome P450 3A4, GABA A receptor alpha-3/beta-2/gamma-2","drug_class":"Benzodiazepine (short-acting)","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"lorazepam","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ativan","generic_name":"lorazepam","company_name":"Generic (originally Wyeth/Pfizer)","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2, Fatty acid-binding protein, liver","drug_class":"Benzodiazepine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"pethidine","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pethidine","company_name":"","drug_phase":"unknown","molecular_target":"Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"diprivan","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diprivan","company_name":"St. Antonius Hospital","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C9, Fatty-acid amide hydrolase 1, Transient receptor potential cation channel subfamily V member 4","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"pethidin","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pethidin","company_name":"Ain Shams University","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"demerol","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meperidine Hydrochloride Preservative Free","generic_name":"Meperidine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":72,"revenue":null,"mechanism":"Meperidine Hydrochloride Preservative Free works by binding to opioid receptors in the brain, altering the perception of and response to pain."},{"drug_id":"fospropofol","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lusedra","generic_name":"FOSPROPOFOL","company_name":"","drug_phase":"marketed","molecular_target":"GABA-A receptor","drug_class":"fospropofol","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"propofol","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diprivan","generic_name":"Propofol","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"GABA A receptors","drug_class":"General anesthetic","quality_score":10,"revenue":null,"mechanism":"Propofol produces sedative/anesthetic effects by positive modulation of inhibitory GABA function through GABA A receptors."},{"drug_id":"butorphanol","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Stadol Preservative Free","generic_name":"BUTORPHANOL","company_name":"","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Opioid Agonist/Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"lusedra","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lusedra","company_name":"Eisai Inc.","drug_phase":"phase_1","molecular_target":"GABA-A receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":11,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[{"drug_id":"propofol","guideline_body":"FDA label","recommendation":"Propofol injectable emulsion is indicated for initiation and maintenance of monitored anesthesia care (MAC) sedation in adult patients and sedation for adult patients in combination with regional anesthesia.","line_of_therapy":"adj","evidence_grade":"A","guideline_year":null},{"drug_id":"midazolam-hydrochloride","guideline_body":"FDA label","recommendation":"Midazolam injection can be used as a component of intravenous supplementation of nitrous oxide and oxygen (balanced anesthesia).","line_of_therapy":"adj","evidence_grade":"A","guideline_year":null},{"drug_id":"demerol","guideline_body":"FDA label","recommendation":"Meperidine Hydrochloride can be used for sedation as an adjunct to anesthesia.","line_of_therapy":"adj","evidence_grade":"B","guideline_year":null},{"drug_id":"midazolam","guideline_body":"FDA label","recommendation":"Midazolam injection can be used as a component of intravenous supplementation of nitrous oxide and oxygen (balanced anesthesia).","line_of_therapy":"adj","evidence_grade":"A","guideline_year":null}],"source":"Drug Landscape verified database"}